Does Prescription Drug Adherence Reduce Hospitalizations and Costs?

Preprint OPEN
William Encinosa; Didem Bernard; Avi Dor;
(2010)
  • Subject:
    • jel: jel:H51 | jel:I11

We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence a... View more
  • References (19)
    19 references, page 1 of 2

    Baum, C., Shaffer, M. and Stillman, S. (2003), “Instrumental Variables and GMM: Estimation and Testing.” The Stata Journal, Vol. 3 No. 1, pp. 1-31.

    Becker, S. and Ichino, A. (2002), “Estimation of Average Treatment Effects Based on Propensity Scores.” The Stata Journal, Vol. 2 No. 4, pp. 358-377.

    Bradford, D. et al. (2006), “Effects of Direct-to-Consumer Advertising of Hydroxymethylglutaryl Coenzyme A Reductiase Inhibitors on Attainment of LDL-C Goals”, Clinical Therapeutics, Vol. 23 No. 12, pp. 2105-18.

    Dezii, C.M. (2000), “Medication Noncompliance: What is the Problem?”, Managed Care, Vol. 9 No. 9, pp. 7-12.

    Dor, A. (2004), “Optimal Price Rules, Administered Prices and Suboptimal Prevention: Evidence from a Medicare Program”, Journal of Regulatory Economics, Vol. 25 No. 1, pp. 81-104.

    Dor, A. and Encinosa, W. (2004), “Does Cost-Sharing Affect Compliance? The Case of Prescription Drugs”, National Bureau of Economic Research Working Paper 10738, September, 2004. NBER: Cambridge, MA.

    Dor, A. and Encinosa, W. (2010), “How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs. Journal of Economics and Management Strategy, 19:3 forthcoming.

    Fendrick, A.M., Smith, D.G., Chernew, M.E., et al. (2001), “A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost”, American Journal of Managed Care, Vol. 7 No. 9, pp. 861-867.

    Frank, R.G. and Newhouse, J.P. (2008), “Should Drug Prices Be Negotiated Under Part D of Medicare? And If So, How?”, Health Affairs, Vol. 27 No. 1, pp. 33-42.

    Fuhrmans, V. (2004), “A Radical Prescription”, Wall Street Journal, May, 10, 2004. pp.

  • Metrics
Share - Bookmark